详情页 - 首都医科大学附属北京同仁医院知识库

资源类型：

文章类型：

作者：

Zhao Miao-Miao[1,2] *

; Lu Jing[1,2]

; Li Sen[2] ; Wang Hao[1,2,3]

; Cao Xi[1,2]

; Li Qi[2] ; Shi Ting-Ting[1,2]

; Matsunaga Kohichi[3] ; Chen Chen[4] ; Huang Haixia[5] ; Izumi Tetsuro[3] ; Yang Jin-Kui[6,7]

;

机构： [1]Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, 100730, Beijing, China. [2]Beijing Key Laboratory of Diabetes Research and Care, Beijing Diabetes Institute, 100730, Beijing, China. [3]Laboratory of Molecular Endocrinology and Metabolism, Department of Molecular Medicine, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan. [4]School of Biomedical Sciences, University of Queensland, Brisbane, QLD, 4072, Australia. [5]Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, 100069, Beijing, China. [6]Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, 100730, Beijing, China. jkyang@ccmu.edu.cn. [7]Beijing Key Laboratory of Diabetes Research and Care, Beijing Diabetes Institute, 100730, Beijing, China. jkyang@ccmu.edu.cn.

出处：

DOI：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2020]版：

大类 | 1 区

综合性期刊

小类 | 1 区综合性期刊

最新[2023]版：

大类 | 1 区

综合性期刊

小类 | 1 区综合性期刊

第一作者：

第一作者机构： [1]Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, 100730, Beijing, China. [2]Beijing Key Laboratory of Diabetes Research and Care, Beijing Diabetes Institute, 100730, Beijing, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

Author Correction: Berberine is an insulin secretagogue targeting the KCNH6 potassium channel.

文献详情